Shareholders Equity: The sum of preferred and common equity items.
Medicenna Therapeutics Corp. (T.MDN) had Shareholders Equity of 3.81M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
-10.21M |
|
-- |
|
-- |
|
-- |
|
-2.94M |
|
-- |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-2.94M |
|
-2.94M |
|
69.64M |
|
69.64M |
|
-0.15 |
|
-0.15 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.05M |
|
-- |
|
-- |
|
-- |
|
10.24M |
|
3.81M |
|
3.77M |
|
|
Shareholders Equity |
3.81M |
69.64M |
|
| Cash Flow Statement Financials | |
-11.94M |
|
-- |
|
-- |
|
24.68M |
|
12.47M |
|
-12.20M |
|
0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-267.85% |
|
-270.82% |
|
-72.67% |
|
-267.85% |
|
0.07 |
|
-0.17 |
|
-0.17 |
|